Promoting and protecting the health and safety of all Idahoans

Pharmacy and Therapeutics Committee

The Idaho Medicaid Pharmacy and Therapeutics Committee (P&T Committee) is comprised of Idaho health practitioners – physicians, physician assistant, pharmacists – who are committed to providing the right care at the right price. This committee meets four times per year to review clinical evidence. The P&T Committee makes recommendations to the Department of Health and Welfare regarding drug safety and efficacy as well as prior authorization requirements. Cost modeling analysis is done by the department twice per year – following the committee meetings in May and November.

Preferred Drug List (PDL)

General P&T Information

May 15, 2020 - Remote Access Information

+1-415-655-0003 US Toll 
Meeting number (access code): 286 043 259
Meeting password: F78yF677Bed (37893677 from phones and video systems) 

Join by phone 
Tap to call in from a mobile device (attendees only) 
1-415-655-0003 US Toll 
1-720-650-7664 United States Toll (Denver) 

Global call-in numbers 
Join from a video system or application
Dial 286043259@idhw.webex.com 
You can also dial 173.243.2.68 and enter your meeting number


2020 Meeting Dates: 

  • April 17, 2020    
  • May 15, 2020     
  • October 16, 2020    
  • November 20, 2020

Members

Voting Members

  • Andrei Rudyi, PharmD (Boise, serving since 2016)
  • Christopher Streeter, MD (Boise, serving since 2014)
  • David Calley, PharmD (Meridian, serving since 2018)
  • Jeffery Johnson, PharmD, PA (Eagle, serving since 2017)
  • Joseph Weatherly, DO (Idaho Falls, serving since 2017)
  • Perry Brown, MD (Boise, serving since 2009)
  • Paul Driver, PharmD (Lewiston, serving since 2016)
  • Ben Powers, MD (Meridian, serving since 2019)
  • Andrew Baron, MD (Boise, serving since 2019)

Non-Voting Members

  • Magni Hamso, MD, MPH, FACP (Division of Medicaid, Medical Director)
  • Tamara Eide, PharmD (Division of Medicaid, Pharmacy Director)
  • Nicole Chopski, PharmD (Board of Pharmacy, Executive Director)